Whalesbook
India's Semiconductor Ambitions Fuel Supply Chain Opportunities
India is set for a dramatic expansion in its semiconductor market, with projections indicating a rise from approximately $38 billion in 2023 to $100-110 billion (₹9-10 lakh crore) by 2030. This growth trajectory is increasingly looking beyond large-scale fabrication plants to the critical upstream components that enable manufacturing.
The core of this evolving ecosystem lies in the supply chain, which requires highly specialized materials, gases, and process chemicals demanding extreme purity and rigorous qualification. As global dynamics shift manufacturing sourcing away from China, Indian companies are stepping in to fill these vital gaps.
Acutaas Chemicals: A Pioneer in Semiconductor Grade Chemicals
Acutaas Chemicals, previously Ami Organics, is strategically positioning itself as a key supplier. While its primary revenue driver remains Advanced Pharmaceutical Intermediaries (API), the company is actively diversifying into battery chemicals and semiconductors. It is noted as the sole Indian manufacturer of semiconductor-grade photoresist chemicals, essential for chip fabrication processes requiring ultra-high purity.
Further strengthening its global presence, Acutaas formed a joint venture, Indichem Inc., in South Korea. This venture aims to supply advanced semiconductor chemicals to both Korean and international markets, expected to contribute to revenue from the second half of FY27. Acutaas's financial performance shows robust growth, with H1 FY26 revenue up 21% and profit after tax surging 122%.
Archean Chemicals Industries: Entering the Silicon Carbide Market
Archean Chemicals Industries, a leader in marine chemicals like Bromine and Industrial Salt, is embarking on a significant diversification into silicon carbide (SiC) based power devices. The company is establishing India's first commercial compound semiconductor fabrication facility in Odisha, with completion anticipated within 30 months.
This facility will leverage advanced SiC technology through a collaboration with UK-based Clas-SiC Wafer Fab, aiming for an annual capacity of 60,000 wafers. This strategic move aligns with the global SiC market's projected 26% CAGR growth through 2030. Despite a slight dip in EBITDA and PBT in H1 FY26 due to external factors, Archean's expansion into SiC is a major step towards capturing high-growth sectors.
Stallion India Fluorochemicals: Supplying Essential Semiconductor Gases
Stallion India is enhancing its capabilities as a specialized provider of refrigerant and industrial gases, with a strategic focus on the semiconductor gas market. The company is expanding its facilities to produce high-purity semiconductor gases and liquid helium, crucial for electronics, solar cells, and fiber optics.
Key to this strategy is achieving a "6N" purity standard (99.9999%) for semiconductor gases and building capacity for liquid helium processing. Stallion's financial results for H1 FY26 indicate strong growth, with revenue increasing by 52.8% and profit after tax more than doubling, driven by higher volumes and an improved product mix. The company anticipates continued growth and margin expansion as it shifts towards higher-value products.
Impact
These companies' strategic plays in the semiconductor supply chain are pivotal for India's 'Make in India' initiative and its ambition to become a global electronics manufacturing hub. Their success could foster a more robust domestic ecosystem, attract further investment, create skilled jobs, and reduce reliance on foreign suppliers for critical semiconductor components. The financial performance of these companies also presents potential growth opportunities for investors looking at the semiconductor value chain beyond direct manufacturing. The impact rating for this news on the Indian stock market and economy is 8/10.
Difficult Terms Explained
- Fabs: Short for fabrication plants, these are highly complex facilities where semiconductor chips are manufactured.
- API (Advanced Pharmaceutical Intermediaries): Chemical compounds that are crucial building blocks in the manufacturing process of pharmaceutical drugs.
- EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization): A measure of a company's operating performance, excluding the impact of financing, tax, and non-cash expenses.
- Silicon Carbide (SiC): A compound semiconductor material known for its superior properties (like high-temperature resistance and power efficiency) compared to silicon, making it ideal for power electronics in EVs, renewable energy, etc.
- Parts-per-billion (ppb): A unit of concentration, indicating a very small amount of a substance within a larger volume, signifying extreme purity required for semiconductor chemicals.
- CAGR (Compound Annual Growth Rate): The mean annual growth rate of an investment over a specified period longer than one year.
- RoCE (Return on Capital Employed): A profitability ratio that measures how efficiently a company uses its capital to generate profits.
- RoE (Return on Equity): A profitability ratio that measures how much profit a company generates with the money shareholders have invested.
- P/E (Price-to-Earnings) Multiple: A valuation ratio that compares a company's current share price to its per-share earnings, indicating how much investors are willing to pay for each dollar of earnings.